OSRH vs HCWB vs AEYE vs NXPL vs CLPS

For growth investors, CLPS Incorporation (CLPS) is the stronger pick with 15.

2% revenue growth year-over-year, versus -97. 9% for HCW Biologics Inc. (HCWB). The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, AudioEye, Inc.

(AEYE) delivered a total return of -60. 2%, compared to -99. 9% for HCW Biologics Inc. (HCWB). Over 10 years, the gap is even starker: AEYE returned +102. 2% versus HCWB's -99. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CLPS Incorporation (CLPS) is the lower-risk stock at 0.

27β versus AudioEye, Inc. 's 2. 29β — meaning AEYE is approximately 743% more volatile than CLPS relative to the S&P 500. On balance sheet safety, NextPlat Corp (NXPL) carries a lower debt/equity ratio of 9% versus 2% for HCW Biologics Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), CLPS Incorporation (CLPS) is pulling ahead at 15.

2% versus -97. 9% for HCW Biologics Inc. (HCWB). On earnings-per-share growth, the picture is similar: NextPlat Corp grew EPS 33. 8% year-over-year, compared to -1280. 5% for HCW Biologics Inc.. Over a 3-year CAGR, NXPL leads at 66. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

CLPS Incorporation (CLPS) is the more profitable company, earning -4.

3% net margin versus -146. 8% for HCW Biologics Inc. — meaning it keeps -4. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CLPS leads at -4. 0% versus -207. 6% for HCWB. At the gross margin level — before operating expenses — AEYE leads at 78. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, CLPS (14.

6% yield) pays a dividend. OSRH, HCWB, AEYE, NXPL do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, CLPS Incorporation (CLPS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

27), 14. 6% yield). OSR Holdings, Inc. (OSRH) carries a higher beta of 1. 90 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CLPS: -78. 5%, OSRH: -93. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (OSRH (Healthcare) and HCWB (Healthcare) and AEYE (Technology) and NXPL (Technology) and CLPS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: OSRH is a small-cap quality compounder stock; HCWB is a small-cap quality compounder stock; AEYE is a small-cap quality compounder stock; NXPL is a small-cap quality compounder stock; CLPS is a small-cap high-growth stock. CLPS pays a dividend while OSRH, HCWB, AEYE, NXPL do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.